The number of hospital discharges for deforming dorsopathies and spondylopathies in France is expected to show a steady increase from 2024 to 2028, starting at 80.19 thousand and reaching 87.05 thousand. The year-on-year growth reveals a consistent upward trend, with yearly increases suggesting a gradual rise in the prevalence or diagnosis of these conditions. The forecasted data indicates a Compound Annual Growth Rate (CAGR) over this period, highlighting a relatively stable rate of increase, which suggests a persistent demand for related healthcare services.

Future trends to watch for include:

Technological advancements in diagnostics and treatment that may influence hospital discharge rates.
Changes in healthcare policy or reimbursement models impacting treatment practices for dorsopathies and spondylopathies.
Demographic shifts, such as an aging population, potentially leading to higher incidences of these conditions.